img

Global Bipolar Disorder Therapeutic Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Bipolar Disorder Therapeutic Market Research Report 2024

Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. According to Pfizer, Inc., bipolar disorder affects over 5 million people in the U.S. Bipolar episodes are characterized by a drastic change in behavior and mood, and range from joyful and overexcited (manic episodes) to extremely sad and hopeless (depressive state). These disorders have different types of episodes such as manic episodes, hypomanic episodes, depressive episodes, and mixed episodes. Causes of bipolar disorders include childhood trauma, stressful life events, self-esteem problems, and genetic inheritance. People across the world marked “March 30” as a World Bipolar Day to spread awareness about the disorder and erase the stigma of mental illness. Large number of people suffering from this mental condition resort to drinking to lift their mood. According to the National Institute on Alcohol Abuse and Alcoholism, 27.6% of the people with bipolar disorder become addicted to alcohol, while over 16% engaged in alcohol abuse.
According to Mr Accuracy reports’s new survey, global Bipolar Disorder Therapeutic market is projected to reach US$ 4443.3 million in 2034, increasing from US$ 3855.3 million in 2022, with the CAGR of 2.0% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Bipolar Disorder Therapeutic market research.
The growing need to reduce the financial burden of bipolar disorder will drive the growth prospects for the global bipolar disorder therapeutic market until the end of 2021. It has been observed that governments and companies across the globe are increasingly organizing awareness camps to raise disease awareness among the public, reduce the burden of mental disorders in vulnerable groups, ensure the rights of people with mental disorders, and make treatment facilities accessible to them. Consequently, such awareness initiatives help to curb the overall monetary loss, reduce their effect on the global economy, and improve the quality of life for patients. Such factors will raise public awareness about mental disorders and treatments and in turn, propel the rate of revenue generation in the market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bipolar Disorder Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Allergan
Astellas Pharma
GlaxoSmithKline
Janssen Pharmaceuticals
Segment by Type
Antipsychotics
Anticonvulsants
Mood Stabilizers

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Bipolar Disorder Therapeutic report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Bipolar Disorder Therapeutic Market Overview
1.1 Product Overview and Scope of Bipolar Disorder Therapeutic
1.2 Bipolar Disorder Therapeutic Segment by Type
1.2.1 Global Bipolar Disorder Therapeutic Market Value Comparison by Type (2024-2034)
1.2.2 Antipsychotics
1.2.3 Anticonvulsants
1.2.4 Mood Stabilizers
1.3 Bipolar Disorder Therapeutic Segment by Application
1.3.1 Global Bipolar Disorder Therapeutic Market Value by Application: (2024-2034)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Bipolar Disorder Therapeutic Market Size Estimates and Forecasts
1.4.1 Global Bipolar Disorder Therapeutic Revenue 2018-2034
1.4.2 Global Bipolar Disorder Therapeutic Sales 2018-2034
1.4.3 Global Bipolar Disorder Therapeutic Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Bipolar Disorder Therapeutic Market Competition by Manufacturers
2.1 Global Bipolar Disorder Therapeutic Sales Market Share by Manufacturers (2018-2024)
2.2 Global Bipolar Disorder Therapeutic Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Bipolar Disorder Therapeutic Average Price by Manufacturers (2018-2024)
2.4 Global Bipolar Disorder Therapeutic Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Bipolar Disorder Therapeutic, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bipolar Disorder Therapeutic, Product Type & Application
2.7 Bipolar Disorder Therapeutic Market Competitive Situation and Trends
2.7.1 Bipolar Disorder Therapeutic Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bipolar Disorder Therapeutic Players Market Share by Revenue
2.7.3 Global Bipolar Disorder Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bipolar Disorder Therapeutic Retrospective Market Scenario by Region
3.1 Global Bipolar Disorder Therapeutic Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Bipolar Disorder Therapeutic Global Bipolar Disorder Therapeutic Sales by Region: 2018-2034
3.2.1 Global Bipolar Disorder Therapeutic Sales by Region: 2018-2024
3.2.2 Global Bipolar Disorder Therapeutic Sales by Region: 2024-2034
3.3 Global Bipolar Disorder Therapeutic Global Bipolar Disorder Therapeutic Revenue by Region: 2018-2034
3.3.1 Global Bipolar Disorder Therapeutic Revenue by Region: 2018-2024
3.3.2 Global Bipolar Disorder Therapeutic Revenue by Region: 2024-2034
3.4 North America Bipolar Disorder Therapeutic Market Facts & Figures by Country
3.4.1 North America Bipolar Disorder Therapeutic Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Bipolar Disorder Therapeutic Sales by Country (2018-2034)
3.4.3 North America Bipolar Disorder Therapeutic Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bipolar Disorder Therapeutic Market Facts & Figures by Country
3.5.1 Europe Bipolar Disorder Therapeutic Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Bipolar Disorder Therapeutic Sales by Country (2018-2034)
3.5.3 Europe Bipolar Disorder Therapeutic Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bipolar Disorder Therapeutic Market Facts & Figures by Country
3.6.1 Asia Pacific Bipolar Disorder Therapeutic Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Bipolar Disorder Therapeutic Sales by Country (2018-2034)
3.6.3 Asia Pacific Bipolar Disorder Therapeutic Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bipolar Disorder Therapeutic Market Facts & Figures by Country
3.7.1 Latin America Bipolar Disorder Therapeutic Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Bipolar Disorder Therapeutic Sales by Country (2018-2034)
3.7.3 Latin America Bipolar Disorder Therapeutic Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bipolar Disorder Therapeutic Market Facts & Figures by Country
3.8.1 Middle East and Africa Bipolar Disorder Therapeutic Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Bipolar Disorder Therapeutic Sales by Country (2018-2034)
3.8.3 Middle East and Africa Bipolar Disorder Therapeutic Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Bipolar Disorder Therapeutic Sales by Type (2018-2034)
4.1.1 Global Bipolar Disorder Therapeutic Sales by Type (2018-2024)
4.1.2 Global Bipolar Disorder Therapeutic Sales by Type (2024-2034)
4.1.3 Global Bipolar Disorder Therapeutic Sales Market Share by Type (2018-2034)
4.2 Global Bipolar Disorder Therapeutic Revenue by Type (2018-2034)
4.2.1 Global Bipolar Disorder Therapeutic Revenue by Type (2018-2024)
4.2.2 Global Bipolar Disorder Therapeutic Revenue by Type (2024-2034)
4.2.3 Global Bipolar Disorder Therapeutic Revenue Market Share by Type (2018-2034)
4.3 Global Bipolar Disorder Therapeutic Price by Type (2018-2034)
5 Segment by Application
5.1 Global Bipolar Disorder Therapeutic Sales by Application (2018-2034)
5.1.1 Global Bipolar Disorder Therapeutic Sales by Application (2018-2024)
5.1.2 Global Bipolar Disorder Therapeutic Sales by Application (2024-2034)
5.1.3 Global Bipolar Disorder Therapeutic Sales Market Share by Application (2018-2034)
5.2 Global Bipolar Disorder Therapeutic Revenue by Application (2018-2034)
5.2.1 Global Bipolar Disorder Therapeutic Revenue by Application (2018-2024)
5.2.2 Global Bipolar Disorder Therapeutic Revenue by Application (2024-2034)
5.2.3 Global Bipolar Disorder Therapeutic Revenue Market Share by Application (2018-2034)
5.3 Global Bipolar Disorder Therapeutic Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Eli Lilly Bipolar Disorder Therapeutic Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Corporation Information
6.2.2 Bristol-Myers Squibb Description and Business Overview
6.2.3 Bristol-Myers Squibb Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Bristol-Myers Squibb Bipolar Disorder Therapeutic Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2018-2024)
6.3.4 AstraZeneca Bipolar Disorder Therapeutic Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Allergan
6.4.1 Allergan Corporation Information
6.4.2 Allergan Description and Business Overview
6.4.3 Allergan Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Allergan Bipolar Disorder Therapeutic Product Portfolio
6.4.5 Allergan Recent Developments/Updates
6.5 Astellas Pharma
6.5.1 Astellas Pharma Corporation Information
6.5.2 Astellas Pharma Description and Business Overview
6.5.3 Astellas Pharma Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Astellas Pharma Bipolar Disorder Therapeutic Product Portfolio
6.5.5 Astellas Pharma Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2018-2024)
6.6.4 GlaxoSmithKline Bipolar Disorder Therapeutic Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Janssen Pharmaceuticals
6.6.1 Janssen Pharmaceuticals Corporation Information
6.6.2 Janssen Pharmaceuticals Description and Business Overview
6.6.3 Janssen Pharmaceuticals Bipolar Disorder Therapeutic Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Janssen Pharmaceuticals Bipolar Disorder Therapeutic Product Portfolio
6.7.5 Janssen Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bipolar Disorder Therapeutic Industry Chain Analysis
7.2 Bipolar Disorder Therapeutic Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bipolar Disorder Therapeutic Production Mode & Process
7.4 Bipolar Disorder Therapeutic Sales and Marketing
7.4.1 Bipolar Disorder Therapeutic Sales Channels
7.4.2 Bipolar Disorder Therapeutic Distributors
7.5 Bipolar Disorder Therapeutic Customers
8 Bipolar Disorder Therapeutic Market Dynamics
8.1 Bipolar Disorder Therapeutic Industry Trends
8.2 Bipolar Disorder Therapeutic Market Drivers
8.3 Bipolar Disorder Therapeutic Market Challenges
8.4 Bipolar Disorder Therapeutic Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Bipolar Disorder Therapeutic Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Bipolar Disorder Therapeutic Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Bipolar Disorder Therapeutic Market Competitive Situation by Manufacturers in 2022
Table 4. Global Bipolar Disorder Therapeutic Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Bipolar Disorder Therapeutic Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Bipolar Disorder Therapeutic Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Bipolar Disorder Therapeutic Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Bipolar Disorder Therapeutic Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Bipolar Disorder Therapeutic, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Bipolar Disorder Therapeutic, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Bipolar Disorder Therapeutic, Product Type & Application
Table 12. Global Key Manufacturers of Bipolar Disorder Therapeutic, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Bipolar Disorder Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder Therapeutic as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Bipolar Disorder Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Bipolar Disorder Therapeutic Sales by Region (2018-2024) & (K Units)
Table 18. Global Bipolar Disorder Therapeutic Sales Market Share by Region (2018-2024)
Table 19. Global Bipolar Disorder Therapeutic Sales by Region (2024-2034) & (K Units)
Table 20. Global Bipolar Disorder Therapeutic Sales Market Share by Region (2024-2034)
Table 21. Global Bipolar Disorder Therapeutic Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Bipolar Disorder Therapeutic Revenue Market Share by Region (2018-2024)
Table 23. Global Bipolar Disorder Therapeutic Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Bipolar Disorder Therapeutic Revenue Market Share by Region (2024-2034)
Table 25. North America Bipolar Disorder Therapeutic Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Bipolar Disorder Therapeutic Sales by Country (2018-2024) & (K Units)
Table 27. North America Bipolar Disorder Therapeutic Sales by Country (2024-2034) & (K Units)
Table 28. North America Bipolar Disorder Therapeutic Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Bipolar Disorder Therapeutic Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Bipolar Disorder Therapeutic Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Bipolar Disorder Therapeutic Sales by Country (2018-2024) & (K Units)
Table 32. Europe Bipolar Disorder Therapeutic Sales by Country (2024-2034) & (K Units)
Table 33. Europe Bipolar Disorder Therapeutic Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Bipolar Disorder Therapeutic Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Bipolar Disorder Therapeutic Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Bipolar Disorder Therapeutic Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Bipolar Disorder Therapeutic Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Bipolar Disorder Therapeutic Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Bipolar Disorder Therapeutic Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Bipolar Disorder Therapeutic Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Bipolar Disorder Therapeutic Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Bipolar Disorder Therapeutic Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Bipolar Disorder Therapeutic Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Bipolar Disorder Therapeutic Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Bipolar Disorder Therapeutic Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Bipolar Disorder Therapeutic Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Bipolar Disorder Therapeutic Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Bipolar Disorder Therapeutic Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Bipolar Disorder Therapeutic Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Bipolar Disorder Therapeutic Sales (K Units) by Type (2018-2024)
Table 51. Global Bipolar Disorder Therapeutic Sales (K Units) by Type (2024-2034)
Table 52. Global Bipolar Disorder Therapeutic Sales Market Share by Type (2018-2024)
Table 53. Global Bipolar Disorder Therapeutic Sales Market Share by Type (2024-2034)
Table 54. Global Bipolar Disorder Therapeutic Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Bipolar Disorder Therapeutic Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Bipolar Disorder Therapeutic Revenue Market Share by Type (2018-2024)
Table 57. Global Bipolar Disorder Therapeutic Revenue Market Share by Type (2024-2034)
Table 58. Global Bipolar Disorder Therapeutic Price (USD/Unit) by Type (2018-2024)
Table 59. Global Bipolar Disorder Therapeutic Price (USD/Unit) by Type (2024-2034)
Table 60. Global Bipolar Disorder Therapeutic Sales (K Units) by Application (2018-2024)
Table 61. Global Bipolar Disorder Therapeutic Sales (K Units) by Application (2024-2034)
Table 62. Global Bipolar Disorder Therapeutic Sales Market Share by Application (2018-2024)
Table 63. Global Bipolar Disorder Therapeutic Sales Market Share by Application (2024-2034)
Table 64. Global Bipolar Disorder Therapeutic Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Bipolar Disorder Therapeutic Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Bipolar Disorder Therapeutic Revenue Market Share by Application (2018-2024)
Table 67. Global Bipolar Disorder Therapeutic Revenue Market Share by Application (2024-2034)
Table 68. Global Bipolar Disorder Therapeutic Price (USD/Unit) by Application (2018-2024)
Table 69. Global Bipolar Disorder Therapeutic Price (USD/Unit) by Application (2024-2034)
Table 70. Eli Lilly Corporation Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly Bipolar Disorder Therapeutic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Eli Lilly Bipolar Disorder Therapeutic Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. Bristol-Myers Squibb Corporation Information
Table 76. Bristol-Myers Squibb Description and Business Overview
Table 77. Bristol-Myers Squibb Bipolar Disorder Therapeutic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Bristol-Myers Squibb Bipolar Disorder Therapeutic Product
Table 79. Bristol-Myers Squibb Recent Developments/Updates
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Business Overview
Table 82. AstraZeneca Bipolar Disorder Therapeutic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. AstraZeneca Bipolar Disorder Therapeutic Product
Table 84. AstraZeneca Recent Developments/Updates
Table 85. Allergan Corporation Information
Table 86. Allergan Description and Business Overview
Table 87. Allergan Bipolar Disorder Therapeutic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Allergan Bipolar Disorder Therapeutic Product
Table 89. Allergan Recent Developments/Updates
Table 90. Astellas Pharma Corporation Information
Table 91. Astellas Pharma Description and Business Overview
Table 92. Astellas Pharma Bipolar Disorder Therapeutic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Astellas Pharma Bipolar Disorder Therapeutic Product
Table 94. Astellas Pharma Recent Developments/Updates
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Bipolar Disorder Therapeutic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. GlaxoSmithKline Bipolar Disorder Therapeutic Product
Table 99. GlaxoSmithKline Recent Developments/Updates
Table 100. Janssen Pharmaceuticals Corporation Information
Table 101. Janssen Pharmaceuticals Description and Business Overview
Table 102. Janssen Pharmaceuticals Bipolar Disorder Therapeutic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Janssen Pharmaceuticals Bipolar Disorder Therapeutic Product
Table 104. Janssen Pharmaceuticals Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Bipolar Disorder Therapeutic Distributors List
Table 108. Bipolar Disorder Therapeutic Customers List
Table 109. Bipolar Disorder Therapeutic Market Trends
Table 110. Bipolar Disorder Therapeutic Market Drivers
Table 111. Bipolar Disorder Therapeutic Market Challenges
Table 112. Bipolar Disorder Therapeutic Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bipolar Disorder Therapeutic
Figure 2. Global Bipolar Disorder Therapeutic Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Bipolar Disorder Therapeutic Market Share by Type in 2022 & 2034
Figure 4. Antipsychotics Product Picture
Figure 5. Anticonvulsants Product Picture
Figure 6. Mood Stabilizers Product Picture
Figure 7. Global Bipolar Disorder Therapeutic Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Bipolar Disorder Therapeutic Market Share by Application in 2022 & 2034
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Bipolar Disorder Therapeutic Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Bipolar Disorder Therapeutic Market Size (2018-2034) & (US$ Million)
Figure 14. Global Bipolar Disorder Therapeutic Sales (2018-2034) & (K Units)
Figure 15. Global Bipolar Disorder Therapeutic Average Price (USD/Unit) & (2018-2034)
Figure 16. Bipolar Disorder Therapeutic Report Years Considered
Figure 17. Bipolar Disorder Therapeutic Sales Share by Manufacturers in 2022
Figure 18. Global Bipolar Disorder Therapeutic Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Bipolar Disorder Therapeutic Players: Market Share by Revenue in 2022
Figure 20. Bipolar Disorder Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Bipolar Disorder Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 22. North America Bipolar Disorder Therapeutic Sales Market Share by Country (2018-2034)
Figure 23. North America Bipolar Disorder Therapeutic Revenue Market Share by Country (2018-2034)
Figure 24. U.S. Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Canada Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Europe Bipolar Disorder Therapeutic Sales Market Share by Country (2018-2034)
Figure 27. Europe Bipolar Disorder Therapeutic Revenue Market Share by Country (2018-2034)
Figure 28. Germany Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. France Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. U.K. Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Italy Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Russia Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Asia Pacific Bipolar Disorder Therapeutic Sales Market Share by Region (2018-2034)
Figure 34. Asia Pacific Bipolar Disorder Therapeutic Revenue Market Share by Region (2018-2034)
Figure 35. China Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Japan Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. South Korea Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. India Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Australia Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Taiwan Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Indonesia Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Thailand Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Malaysia Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Philippines Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Latin America Bipolar Disorder Therapeutic Sales Market Share by Country (2018-2034)
Figure 46. Latin America Bipolar Disorder Therapeutic Revenue Market Share by Country (2018-2034)
Figure 47. Mexico Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Brazil Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Argentina Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Middle East & Africa Bipolar Disorder Therapeutic Sales Market Share by Country (2018-2034)
Figure 51. Middle East & Africa Bipolar Disorder Therapeutic Revenue Market Share by Country (2018-2034)
Figure 52. Turkey Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Saudi Arabia Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. U.A.E Bipolar Disorder Therapeutic Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Global Sales Market Share of Bipolar Disorder Therapeutic by Type (2018-2034)
Figure 56. Global Revenue Market Share of Bipolar Disorder Therapeutic by Type (2018-2034)
Figure 57. Global Bipolar Disorder Therapeutic Price (USD/Unit) by Type (2018-2034)
Figure 58. Global Sales Market Share of Bipolar Disorder Therapeutic by Application (2018-2034)
Figure 59. Global Revenue Market Share of Bipolar Disorder Therapeutic by Application (2018-2034)
Figure 60. Global Bipolar Disorder Therapeutic Price (USD/Unit) by Application (2018-2034)
Figure 61. Bipolar Disorder Therapeutic Value Chain
Figure 62. Bipolar Disorder Therapeutic Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed